Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nexalin TechnologyNXL +0.18%38 Market Cap is $7.29 Mil as of Aug. 20, 2026. GuruFocus rates NXL with a GF Score™ of 38/100 and a GF Value™ of $0.66 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 859 Medical Devices & Instruments companies, Nexalin Technology ranks worse than 87.89% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nexalin Technology's share price for the quarter that ended in Jun. 2026 was $0.33. Nexalin Technology's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 22.00 Mil. Therefore, Nexalin Technology's market cap for the quarter that ended in Jun. 2026 was $7.26 Mil.
Nexalin Technology's quarterly market cap
declined
from Dec. 2025 ($10.71 Mil) to Mar. 2026 ($7.17 Mil) but then
increased
from Mar. 2026 ($7.17 Mil) to Jun. 2026 ($7.26 Mil).
Nexalin Technology's annual market cap
increased
from Dec. 2023 ($3.01 Mil) to Dec. 2024 ($36.72 Mil) but then
declined
from Dec. 2024 ($36.72 Mil) to Dec. 2025 ($10.71 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nexalin Technology's Enterprise Value for Today is $6.28 Mil.
Nexalin Technology (NAS:NXL) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Nexalin Technology Market Cap Related Terms
Nexalin Technology Market Cap Historical Data
* Premium members only.
The historical data trend for Nexalin Technology's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nexalin Technology's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nexalin Technology Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nexalin Technology's Market Cap distribution charts can be found below:
* The bar in red indicates where Nexalin Technology's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Nexalin Technology's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nexalin Technology (NXL) has a Market Cap of $7.29 Mil as of Aug. 20, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nexalin Technology and its competitors. According to the industry distribution chart, Nexalin Technology ranks #755 out of 859 companies in the Medical Devices & Instruments industry, placing it in the top 87.9%.
Is Nexalin Technology's Market Cap too high?
Nexalin Technology's current Market Cap is $7.29 Mil. The Medical Devices & Instruments industry median Market Cap is 117.94. Nexalin Technology's value of $7.29 Mil is 93.8% below this industry median. Based on the distribution chart, Nexalin Technology ranks #755 out of 859 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Nexalin Technology has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nexalin Technology's Market Cap compare to ICCM and ADGM?
According to the Medical Devices & Instruments industry distribution chart, Nexalin Technology ranks #755 out of 859 companies for Market Cap. This places Nexalin Technology in the lower half of its industry. The industry median Market Cap is 117.94. Nexalin Technology's value of $7.29 Mil is 93.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 117.94, based on 859 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nexalin Technology's current Market Cap of $7.29 Mil is 93.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nexalin Technology and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 117.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nexalin Technology's current Market Cap is $7.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexalin Technology stock overvalued right now?
Based on GuruFocus' analysis, Nexalin Technology (NXL) is currently considered Possible Value Trap. The stock's GF Value™ is $0.66, compared to a current price of $0.33 — trading 49.9% below its estimated fair value. The current Market Cap is $7.29 Mil and 93.8% below the Medical Devices & Instruments industry median of 117.94. Nexalin Technology's overall GF Score™ is 38/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Nexalin Technology (NXL), the current Market Cap is $7.29 Mil as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nexalin Technology (NXL) Overvalued in 2026?
Based on GuruFocus' analysis, Nexalin Technology stock appears to be undervalued.
The current stock price of $0.33 is trading 49.9% below its estimated GF Value™ of $0.66.
GuruFocus considers Nexalin Technology to be Possible Value Trap.
Key valuation signals for NXL:
Market Cap: $7.29 Mil
GF Value™: $0.66 vs. price of $0.33 (49.9% below fair value)
Industry Position: 93.8% below the Medical Devices & Instruments median (#755 of 859)
No single metric tells the full story. See the NXL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
38GF Score
Get the complete analysis for NXL
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NXL has been successfully added to your 
